The eligibility under the Nairobi Protocol of an Extremit-Ease Compression Garment from China
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Ruling text
In your letter dated July 10, 2025, you requested a tariff classification ruling. A sample (SKU#E010142) that was submitted in a previous ruling was examined and disposed of. The Extremit-Ease Compression Garment is a circumferential gauntlet that provides 30-50 mmHg compression to help reduce mild to moderate swelling from lymphedema, chronic venous insufficiency, acute port-operative edema, and other swelling disorders.
You clarify that the other swelling disorders refer to less common but still chronic medical conditions, such as lipedema, chronic kidney disease, etc., that can present in the form of edema in the lower extremities. The Extremit-Ease Compression Garment consists of a textile compression wrap featuring a zipper and four pull tabs with bungee laces, an EXTREMIT-EASE Garment Liner (a mild compression liner), and a mesh laundry bag, packaged in a retail bag for sale.
The compression wrap is intended to be worn from the calf to the ankle on either leg. The Extremit-Ease Compression Garment is available in various sizes and lengths. You explain that compression garments are “graded” based upon the level of compression provided. Higher compression levels are designed more for those with chronic edema. The Extremit-Ease Compression Garment is classified as “Extra Firm” compression, or “Medical” Compression where a prescription is needed.
You state that due to the complex design, the high profile of the product and the compression levels attained, this product is discernable by the average consumer as a much more robust compression garment. Non-handicapped individuals seeking compression for occasional symptoms would gravitate toward stockings or garments of lower compression and complexity.
You claim that the device is used primarily for patients with chronic medical conditions verses acute post-operative conditions and is predominantly sold to physicians to dispense to their patients based on your sale tracings. You confirm that this product was specifically designed to provide 30-50mmHG of compression to assist patients suffering from chronic conditions such as lymphedema and chronic venous insufficiency.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N351227).